SCHEMBL8351194

SCHEMBL8351194

Cc1cnc(Nc2ccccc2)cc1-c1ccc(C(=O)NCc2ccccc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 1/20 0.55
▸ EGFR P00533 3/20 0.52
▸ MAPK1 P28482 3/20 0.50
▸ ROCK2 O75116 1/20 0.50
▸ RPS6KA5 O75582 1/20 0.50
▸ MAP4K4 O95819 1/20 0.50
▸ PRKCG P05129 1/20 0.50
▸ PRKACA P17612 1/20 0.50
▸ RPS6KB1 P23443 1/20 0.50
▸ AKT1 P31749 1/20 0.50
▸ GSK3A P49840 1/20 0.50
▸ GSK3B P49841 1/20 0.50
▸ PRKX P51817 1/20 0.50
▸ PRKCD Q05655 1/20 0.50
▸ PRKG2 Q13237 1/20 0.50
▸ ROCK1 Q13464 1/20 0.50
▸ DYRK1A Q13627 1/20 0.50
▸ PRKG1 Q13976 1/20 0.50
▸ PKN2 Q16513 1/20 0.50
▸ CDC42BPA Q5VT25 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8349797 0.85 PTPN1 (0.52) MAPK14ALDH1A1LMNARAB9A
SCHEMBL8351466 0.80 ROCK2 (0.64) EGFRMAPK1ROCK2RPS6KA5MAP4K4
SCHEMBL14348409 0.78 CCNA2 (0.54) EGFRMAPK1ROCK2RPS6KA5MAP4K4
SCHEMBL8349130 0.78 MAPK14 (0.52) MAPK14MAPTALDH1A1HPGDJAK3
SCHEMBL8352845 0.75 GRM5 (0.65) MAPK14MAPK1ALDH1A1HPGDRAB9A
SCHEMBL8351620 0.74 HPGD (0.57) CLK4MAPTALDH1A1HPGDHDAC1
SCHEMBL8350880 0.74 MAPK8 (0.54) MAPK14MAPK1ROCK2RPS6KA5MAP4K4
SCHEMBL20145449 0.72 MAPK1 (0.69) MAPK14EGFRMAPK1ROCK2RPS6KA5
SCHEMBL8352104 0.72 CFD (0.59) ROCK2MAP4K4PRKCGROCK1PKN2
SCHEMBL4863522 0.71 MAPK14 (1.00) MAPK14EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7312227-B2 Compositions useful as inhibitors of JAK and other protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-12-25 — — US disclosed
US-7312227-B2 Compositions useful as inhibitors of JAK and other protein kinases VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-12-25 — — US disclosed
WO-2004041789-A1 COMPOSITIONS USEFUL AS INHIBITORS OF JAK AND OTHER PROTEIN KINASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2004-05-21 — — WO disclosed
Send feedback